Section 182-530-7000. Reimbursement.  


Latest version.
  • (1) The agency's total reimbursement for a prescription drug must not exceed the lowest of:
    (a) Estimated acquisition cost (EAC) plus a dispensing fee;
    (b) Maximum allowable cost (MAC) plus a dispensing fee;
    (c) Federal upper limit (FUL) plus a dispensing fee;
    (d) Actual acquisition cost (AAC) plus a dispensing fee for drugs purchased under section 340B of the Public Health Service (PHS) Act;
    (e) Automated maximum allowable cost (AMAC) plus a dispensing fee; or
    (f) The provider's usual and customary charge to the nonmedicaid population.
    (2) The agency selects the sources for pricing information used to set EAC and MAC.
    (3) The agency may solicit assistance from pharmacy providers, pharmacy benefit managers (PBM), other government agencies, actuaries, and/or other consultants when establishing EAC and/or MAC.
    (4) The agency reimburses a pharmacy for the least costly dosage form of a drug within the same route of administration, unless the prescriber has designated a medically necessary specific dosage form or the agency has selected the more expensive dosage form as a preferred drug.
    (5) If the pharmacy provider offers a discount, rebate, promotion or other incentive which directly relates to the reduction of the price of a prescription to the individual nonmedicaid customer, the provider must similarly reduce its charge to the agency for the prescription.
    (6) If the pharmacy provider gives an otherwise covered product for free to the general public, the pharmacy must not submit a claim to the agency.
    (7) The agency does not reimburse for:
    (a) Prescriptions written on presigned prescription blanks filled out by nursing facility operators or pharmacists;
    (b) Prescriptions without the date of the original order;
    (c) Drugs used to replace those taken from a nursing facility emergency kit;
    (d) Drugs used to replace a physician's stock supply;
    (e) Outpatient drugs, biological products, insulin, supplies, appliances, and equipment included in other reimbursement methods including, but not limited to:
    (i) Diagnosis-related group (DRG);
    (ii) Ratio of costs-to-charges (RCC);
    (iii) Nursing facility daily rates;
    (iv) Managed care capitation rates;
    (v) Block grants; or
    (vi) Drugs prescribed for clients who are on the agency's hospice program when the drugs are related to the client's terminal illness and related condition.
    (f) Hemophilia and von Willebrand related products shipped to clients for administration in the home unless the products are provided through a qualified hemophilia treatment center of excellence (COE) as defined in WAC 182-531-1625.
    [Statutory Authority: RCW 41.05.021. WSR 12-16-061, § 182-530-7000, filed 7/30/12, effective 11/1/12. WSR 11-14-075, recodified as § 182-530-7000, filed 6/30/11, effective 7/1/11. Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.530, and 74.09.700. WSR 07-20-049, § 388-530-7000, filed 9/26/07, effective 11/1/07.]
RCW 41.05.021. WSR 12-16-061, § 182-530-7000, filed 7/30/12, effective 11/1/12. WSR 11-14-075, recodified as § 182-530-7000, filed 6/30/11, effective 7/1/11. Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.530, and 74.09.700. WSR 07-20-049, § 388-530-7000, filed 9/26/07, effective 11/1/07.

Rules

182-531-1625,